Company
Fresenius Medical Care
NYSE:FMS
Fresenius Medical Care is an integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure
5 stories
Akorn shares slip after court rules that Fresenius can cancel its buyout of the generic drugmaker
Fresenius scrapped the merger after an investigation found Akorn had a history of fraudulent product data submissions
Investments and investor services
EARLY MOVERS: Fresenius down on profit warning; Broadcom surges on results beat
United Natural Foods Inc shares reel from weak earnings, Yelp buoyed by joining S&P MidCap index
Akorn shares plummet after judge rules Fresenius can end its $4.8 billion buyout
Fresenius terminated the merger after an investigation found Akorn had a history of fraudulent product data submissions
NxStage Medical succumbs to US$2bn offer from Fresenius
NxStage develops, manufactures and markets innovative products for the treatment of end-stage renal disease and acute kidney failure